Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermediate
Fa'atauga Fa'atauga PF-07321332 Paxlovid Feso'ota'i Tulaga Fa'atasi ma le Tulaga Maualuga
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Igoa Vailaau | Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate |
Synonyms | Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl) propanoate;(αS,3S)-α-[(tert-Butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl) propanoate |
Numera CAS | 328086-60-8 |
CAT Numera | RF-PI317 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i le selau Kilograms |
Fuafua mole | C13H22N2O5 |
Molecular Weight | 286.33 |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e i le Pa'epa'e Pa'epa'e |
Faailoaina A | IR: E tutusa ma Reference Substance |
Faailoaga B | Taimi Taofi: Tutusa ma Mea Fa'asino |
Ma'imau ile Fa'amago | ≤1.0% |
Toega i luga o le mumu | ≤0.20% |
Le mama nofofua | ≤0.50% |
Aofa'i Fa'aleaga | ≤2.0% |
Metala mamafa (Pb) | ≤20ppm |
Mama | ≥98.0% |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Intermediate of PF-07321332 Paxlovid (CAS 2628280-40-8) ma Boceprevir (CAS 394730-60-0) |
afifi: Fagu, taga pepa alumini, pusa pepa, 25kg / Paʻu, poʻo le tusa ai ma manaʻoga o tagata faʻatau.
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama, susu ma le afaina o meaola faalafua.
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate (CAS 328086-60-8) o le vaeluaga o le PF-07321332 Paxlovid (CAS 2628280-40) -8) ma Boceprevir (CAS 394730-60-0).PF-07321332, o le vaega autu o Paxlovid (PF-07321332 ma Ritonavir) o se suʻesuʻega COVID-19 oral antiviral sui tauva, o se 3C-like protease (3CLPRO) e mafai ona tuʻu gutu faʻalavelave faʻatasi ma aʻafiaga malosi faʻamaʻi e faasaga i le siama SARS-CoV-2. ma le COVID-19.I le aso 6 o Novema 2021, na fa'ailoa mai ai e Pfizer o Paxlovid na fa'aititia tele le falema'i ma le maliu, fa'avae i luga o se su'esu'ega le tumau o le Vaega 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) fa'afuase'i, su'esu'ega fa'alua tauaso. o tagata matutua e lei falemaʻi ma le COVID-19, o loʻo i ai i le maualuga o le lamatiaga o le alualu i luma i gasegase ogaoga.Boceprevir (EBP-520) ose HCV protease inhibitor (Ki=14 nM) mo le togafitia o le hepatitis C siama siama.Boceprevir faʻatasi ai ma le pegylated interferon ma ribavirin (PegIFN / RBV) na mafai ai ona faʻaleleia le faʻaleleia o fua faatatau o tali virological o tagata mamaʻi e maua i le genotype 1 HCV.Boceprevir fegalegaleai ma immunosuppressive togafitiga (IT) e ala i le taofia o le cytochrome P450 3A enzyme.